Mar 01, 2018 - Head-to-head comparison of two Biotech ETFs, XBI and IBB.
Mar 02, 2018 - International Biotechnology Trust Plc Buys Nektar Therapeutics Inc, ACADIA Pharmaceuticals Inc, Exelixis Inc, Sells Illumina Inc, Incyte Corp, Shire PLC, Stocks: NKTR,ACAD,EXEL,SAGE,ARRY,TSRO,ALNY,PRTK,BLUE,SGMO,, release date:Mar 02, 2018
Mar 06, 2018 - Performance for the model account has significantly overtaken the IBB.I discuss with readers the importance of being selective and having a thick filter when picking stocks.We are initiating positions
Mar 20, 2018 - The biotech sector has been a weak performer lately after several bits of bad news came including a clinical hold for Solid Biosciences.Hutchison China Meditech reported an encouraging update on clini
Mar 20, 2018 - Biotechnology stocks are approaching highs achieved in 2015, as reflected by the Nasdaq Biotech Index.New science is opening up great opportunities with boundless potential.The biotech sector also con
Mar 26, 2018 - Weakness in the biotech sector continues to affect many of our holdings.For long term investors weakness and volatility should be seen as an opportunity to add to favorite stocks.Novocure received som
Apr 24, 2018 - President Trump´s speech on drug pricing has been postponed. Continued deal activity in the biotech sector bodes well. Abeona Therapeutics announced receipt of the FDA´s RMAT (Regenerative Medicine Ad
Apr 30, 2018 -
On CNBC's "Mad Money", Jim Cramer advised his viewer to be careful with Array Biopharma Inc (NASDAQ: ARRY) because the market is taking apart the minor drug companies.
May 01, 2018 - Arris Group (NASDAQ:ARRS) turned in a mixed report in Q1 earnings, substantially trimming its net loss but seeing revenues fall short of expectations. Net loss on a GAAP basis was $0.07/share, vs. a
May 03, 2018 - We will initiate coverage on seven biotechnology stocks.These seven companies are primarily picked for their current valuation, pipeline prospects, financial figures, and likelihood of near-term share